Salient Surgical Technologies, Inc., a Portsmouth, NH-based medical technology company that develops and markets advanced energy devices for use in surgical procedures, completed its $15.1m Series G financing.
Investors in the round included Apothecary Capital/BBT Fund, L.P., Arnerich Massena & Associates, Affinity Capital, Medtronic, Inc., and other financial and strategic investors.
Salient will use the proceeds to expand its sales and marketing organization, build upon its health outcomes data and accelerate development of new advanced energy products based on its proprietary Transcollation technology, which allows surgeons to rapidly treat tissue at the surgical site by transforming specific types of collagen based structures to improve patient outcomes.
Salient’s products are currently used in orthopedic reconstruction, spine and surgical oncology.
FinSMEs
25/01/2010